National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
Last trade$205.49
Day change-$1.70 (-0.82%)
Day range$204.99 – $207.90
Volume45,372
Market cap$3.25B
OpenXASE
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$3.25B
Price / earnings
28.3×
Price / book
2.89×
Price / sales
2.05×
EV / sales
2.32×
EV / EBITDA
18.04×
Profitability
Earnings per share
$7.32
Return on assets
5.54%
Return on equity
10.19%
Dividend yield
1.24%
Liquidity and leverage
Debt / equity
0.45×
Current ratio
1.48×
Quick ratio
1.45×
Cash ratio
0.24×
Cash flow
Price / cash flow
14.64×
Price / free cash flow
—
Free cash flow
-$388.63M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for NHC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$407.97M
$408.03M
$381.82M
$386.51M
$382.66M
$374.91M
$373.7M
$369.35M
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$407.97M
$408.03M
$381.82M
$386.51M
$382.66M
$374.91M
$373.7M
$369.35M
Selling, general and administrative
$251.94M
$241.9M
$235.07M
$233.24M
$233.18M
$226.53M
$228.13M
$234.32M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$367.34M
$359.09M
$349.57M
$353.4M
$352.28M
$340.82M
$342.93M
$340.44M
Operating income
$40.63M
$48.94M
$32.25M
$33.12M
$30.38M
$34.09M
$30.77M
$28.91M
Interest expense
-$6.99M
-$13K
-$269K
-$816K
-$1.46M
-$1.99M
-$2.11M
-$2.35M
Income before taxes
$19.68M
$54.01M
$44.82M
$32.13M
$54.41M
$32.17M
$43.72M
$6.06M
Income taxes
$5.5M
$13.47M
$8.71M
$6.94M
$13.4M
$8.06M
$11.43M
$28K
Net income
$14.18M
$40.54M
$36.1M
$25.19M
$41.01M
$24.11M
$32.29M
$6.03M
Net income attributable to common shareholders
$13.64M
$40.32M
$35.86M
$24.85M
$39.24M
$23.72M
$32.21M
$6.08M
EBITDA
$55.21M
$60.11M
$43.87M
$44.89M
$41.54M
$45.11M
$41.75M
$40.35M
Basic earnings per share
$0.87
$2.58
$2.31
$1.60
$2.53
$1.53
$2.09
$0.39
Diluted earnings per share
$0.85
$2.54
$2.27
$1.58
$2.50
$1.52
$2.07
$0.39
Recent news
Company coverage with links to the original publishers.
SDVY, a passively managed ETF focused on mid-cap value stocks with rising dividends, has $10.88 billion in assets and a Zacks ETF Rank of 2 (Buy). With a 0.58% expense ratio and 7.48% YTD return, it offers diversified exposure to 173 holdings primarily in Financials. However, its expense ratio is higher than comparable alternatives like IWS (0.23%) and VOE (0.05%).
The 2026 Tennessee ORBIE Awards recognized seven leading CIOs and CISOs from major Tennessee organizations including FedEx, Nissan Americas, St. Jude Children's Research Hospital, and others for their exceptional leadership in technology and enterprise security. The prestigious awards, hosted by TennesseeCIO and TennesseeCISO chapters, honored executives driving business transformation across various organizational sizes. Over 400 guests attended the event in Nashville.
National HealthCare reported strong Q2 2025 financial performance with 24.7% revenue growth to $374.9 million, driven by facility expansion and same-facility growth. Non-GAAP earnings per share rose 64.7%, though GAAP earnings were impacted by investment losses.
U.S. stocks traded lower, with the Dow Jones index falling more than 100 points on Monday.
Shares of Science Applications International Corporation (NYSE: SAIC) surged during Monday’s session after the company reported third-quarter financial results and raised FY24 guidance above estimates.
SAIC reported a 1% revenue decline Y/Y in Q3 FY24 to $1.895 billion, beating the consensus of $1.790 billion. Adjusted EPS of $2.27 beat the consensus of $1.69.
SAIC raised revenue guidance to $7.325 billion - $7.350 billion (prior $7.20 billion - $7.25 billion). The company increased adjusted EPS guidance to $7.70 - $7.90 (prior $7.20 - $7.40).
Science Applications International shares rose 6.9% to $128.20 on Monday.
Here are some other big stocks recording gains in today’s session.
Hawaiian Holdings, Inc. (NASDAQ: HA) shares jumped 187% to $14.03 after Alaska Air Group, Inc. (NYSE: ALK) announced plans to acquire the company in a deal worth $1.9 billion.
XBP Europe Holdings, Inc. (NASDAQ: XBP) rose 39.5% to $33.28.
Beyond Meat, Inc. ...
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70.
Here’s the latest list of major overbought players in this sector.
Capricor Therapeutics, Inc. (NASDAQ: CAPR)
The company posted better-than-expected quarterly results. “In the second quarter of 2023 we presented positive two-year data from our ongoing HOPE-2 open label extension (OLE) study, which we believe further supports our rapidly advancing late-stage clinical development program for CAP-1002 in patients with Duchenne Muscular Dystrophy (DMD),” said Linda Marbán, Ph.D., Capricor’s chief executive officer. The company’s stock has ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.67 per share
Declared
Nov 5, 2026
Ex-dividend
Dec 31, 2026
Pay date
Jan 29, 2027
Ex-dividend
Amount / share
Pay date
Type
Sep 30, 2026
$0.67
Oct 30, 2026
recurring
Jun 30, 2026
$0.67
Jul 31, 2026
recurring
Mar 31, 2026
$0.64
Apr 30, 2026
recurring
Dec 31, 2025
$0.64
Jan 30, 2026
recurring
Sep 30, 2025
$0.64
Oct 31, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.